Unsere Webseite nutzt Cookies, damit die User-Experience gesteigert wird. Bitte beachten Sie, dass ohne Cookies einige Funktionalitäten nicht mehr ausführbar sind (z. B. Formulare). Ausführlichere Hinweise zu Cookies
OK
  • Conferences and workshops
      Munich 2022
        Manchester 2022
          Copenhagen 2023
        • Network
        • Training and research
        • Call for position
        • Contact
        • Member Area
        1. T-OP 
        2. Network

        Network

        Partners of T-OP

        Beneficiaries

        1. Ludwig-Maximilians-Universität, München
        2. Danmarks Tekniske Universitet, Copenhagen
        3. Amsterdam University Medical Centers, Amsterdam
        4. Institut National de la Santé et de la Recherche Médicale, Tours
        5. Paul-Ehrlich-Institut, Langen
        6. Region Hovedstaden, University Hospital Herlev, Copenhagen
        7. Universität Basel
        8. Roche Glycart AG, Roche Innovation Center Zurich
        9. Instil Bio Inc, Manchester
        10. Université Paris-Saclay
        11. Miltenyi Biotec BV & Co KG, Bergisch Gladbach
        12. Hadassah Medical Organization, Jerusalem

        Asscociated Partners

        13. Université de Tours
        14. Intelligent Omics Ltd, Nottingham
        15. University of Manchester
        16. Institut Gustave Roussy, Paris
        17. University of Copenhagen
        Project Leaders of T-OP
        Sebastian Kobold
        Coordinator Professor and Deputy Director of the Division of Clinical Pharmacology Ludwig-Maximilians-Universität Division of Clinical Pharmacology
         Lindwurmstraße 2a
        D- 80337 München  Germany
        +49 (0) 89 440057325
        E-Mail
        http://www.klinikum.uni-muenchen.de/Abteilung-fuer-Klinische-Pharmakologie/de/index.html
        ORCID-ID
        Michael von Bergwelt
        Director Department of Medicine III, University Hospital, LMU Munich Spokesperson German Cancer Consortium Munich-LMU Ludwig-Maximilians-Universität Medizinische Klinik und Poliklinik III Klinikum der Universität München
         Marchioninistraße 15
        D-81377 Munich Germany
        +49 (0) 89 440075551
        E-Mail
        http://www.klinikum.uni-muenchen.de/Medizinische-Klinik-und-Poliklinik-III/de/team/direktor/index.html
        Pubmed.gov
        Sebastian Theurich
        Professor for Cancer- and Immunometabolism, Attending Physician, Lead of Myeoma Program Ludwig-Maximilians-Universität Gene Center Munich
        Feodor-Lynen-Straße 25 and Department of Medicine III, LMU University Hospital
        D-81377 Munich Germany
        +49 (0) 89 2180 76878
        E-Mail
        https://www.genzentrum.uni-muenchen.de/research-groups/theurich/group-members_new/theurich-sebastian/index.html
        ORCID-ID
        Sine Reker Hadrup
        Professor Danmarks Tekniske Universitet Department of Health Technology Kemitorvet
        Building 204, room 154
        2800 Kgs. Lyngby Denmark
        +45 (0) 35 886290
        E-Mail
        https://www.healthtech.dtu.dk/english
        ORCID-ID
        Tanja D. de Gruijl
        Professor Translational Tumor Immunology and Head of the Immunotherapy Laboratory and the Tumor Immunomonitoring Unit Amsterdam University Medical Centers Dept. Medical Oncology Amsterdam UMC
        VUmc, CCA 2.44 DE BOELELAAN 1117
        1081 HV Amsterdam Post  Netherlands
        +31 (0) 20 4444063
        E-Mail
        https://research.vumc.nl/en/persons/tanja-de-gruijl
        Pubmed.gov
        Christophe Paget
        Senior Researcher at INSERM - UMR1100 Institut National de la Santé et de la Recherche Médicale
        10 boulevard Tonnellé
        37000  Tours France
        +33 (0)247366068
        christophe.paget@univ-tours.fr 
        https://cepr.inserm.univ-tours.fr/english-version
        ORCID-ID
        Christian Buchholz
        Head of Molecular Biotechnology and Gene Therapy Paul-Ehrlich-Institut
        Paul-Ehrlich-Str. 51-59
        63225 Langen Germany
        0049 6103 77 0
        E-Mail
        https://www.pei.de/DE/forschung/forschungsgruppen/praesident/molekulare-biotechnologie-gentherapie-node.html
        ORCID-ID
        Jessica Hartmann
        Senior Research Associate and Regulatory Assessor Paul-Ehrlich-Institut Division of Medical Biotechnology
        Paul-Ehrlich-Str. 51-59
        D-63225 Langen  Germany
        +49 (0) 6103774026
        E-Mail
        https://www.pei.de
        Pubmed.gov
        Per Thor Straten
        Director of Center for Cancer Immunotherapy Region Hovedstaden, University Hospital Herlev Center for Cancer Immunotherapy
        Herlev Ringvej 75
        DK-2730 Herlev  Denmark
        +45 (0) 38 68 93 39
        E-Mail
        https://www.herlevhospital.dk/ccit-denmark/Sider/default.aspx
        ORCID-ID
        Alfred Zippelius
        Head Cancer Immunology Universität Basel Department of Biomedicine (DBM)
        Hebelstrasse 20
        CH-4031Basel Switzerland
        +41 (0)61 265 50 74
        E-Mail
        https://biomedizin.unibas.ch/en/research/research-groups/zippelius-rochlitz-lab/
        Pubmed.gov
        Heinz Läubli
        Research Group Leader of Cancer Immunotherapy Universität Basel Department of Biomedicine (DBM)
        Hebelstrasse 20
        CH-4031Basel Switzerland
        +41 (0)61 265 23 55
        E-Mail
        https://biomedizin.unibas.ch/en/research/research-groups/laeubli-lab/
        ORCID-ID
        Christian Klein
        Department Head Cancer Immunotherapy Discovery 3 & Site Head Roche Innovation Center Zurich, Roche Pharma Research & Early Development Roche Glycart AG, Roche Innovation Center Zurich
        Wagistrasse 10
        CH-8952 Schlieren Switzerland
        +41 (0) 43 215 1628
        E-Mail
        https://www.roche.com
        ORCID-ID
        Robert Hawkins
        Chief Strategy Advisor Instil Bio Inc
        48 Grafton Street
        Manchester M13 9XX UK
        +44 7720708245
        E-Mail
        https://instilbio.com/about/
        Pubmed.gov
        Laurence Zitvogel
        Professor of Immunology at UMR 1015 Immunologie des tumeurs immunothérapie contre le cancer Université Paris-Saclay
        114, rue Édouard-Vaillant
        F- 94805 Villejuif-Cedex France
        +33 (0)1 42 11 42 11
        E-Mail
        https://www.universite-paris-saclay.fr/en
        ORCID-ID
        Jörg Mittelstät
        Group Leader - R&D Reagents CAR technology research and translation - Miltenyi Biotec B.V. & Co. KG
        Friedrich-Ebert-Straße 68
        51429 Bergisch Gladbach Germany
        +49 (0) 02204 8306-0
        E-Mail
        https://www.miltenyibiotec.com/DE-en/?countryRedirected=1
        Pubmed.gov
        Sonja Schallenberg
        Team Coordinator clinical T cell processing development R&D Immunotherapy - Miltenyi Biotec B.V. & Co. KG
        Friedrich-Ebert-Straße 68
        51429  Bergisch Gladbach Germany
        02204 8306-0
        https://www.miltenyibiotec.com/DE-en/?countryRedirected=1
        Pubmed.gov
        Michal Lotem
        Head of Center for Melanoma and Cancer Immunotherapy Sharett Institute Hadassah Medical Organization, HMO
        POB12 000 Jerusalem Israel
        +972-2-677-6781
        E-Mail
        http://www.hadassah-med.com/
        pubmed.gov
        Graham Ball
        CSO Intelligent OMICS Ltd
        C BioCity 1 Pennyfoot Street
        Nottingham NG1 1GF UK
        +44 (0)115 848 8308
        E-Mail
        https://www.intellomx.com/
        ORCID-ID
        Early Stage Researchers of T-OP
        David Andreu Sanz
        ESR1, Kobold's Lab, Division of Clinical Pharmacology, Ludwig-Maximilians-Universität Munich
        Lindwurmstr. 2
        80337  Munich Germany
        E-Mail
        Division of Clinical Pharmacology
        LinkedIn
        Keerthana Ramanathan
        ESR2, Reker's Lab, Danmarks Tekniske Universitet Department of Health Technology Kemitorvet
        Building 204, room 154
        2800 Kgs. Lyngby Denmark
        E-Mail
        Department of Health Technology Kemitorvet
        LinkedIn
        Andreas Kongsgaard
        ESR 3, de Gruijl's Lab, Immunotherapy Laboratory and the Tumor Immunomonitoring Unit Amsterdam University Medical Centers, Dept. Medical Oncology Amsterdam UMC
        VUmc, CCA 2.48 DE BOELELAAN 1117
        081 HV Amsterdam Post Netherlands
        E-Mail
        LinkedIn
        Fabian Richter
        ESR4, Apetoh's Lab, Institut National de la Santé et de la Recherche Médicale INSERM U1100
        10 boulevard Tonnellé
        37000 Tours France
        E-Mail
        CEPR INSERM UMR 1100
        LinkedIn
        Mar Guaza-Lasheras
        ESR 5, Buchholz's Group, Paul-Ehrlich-Institut Division of Medical Biotechnology
        Paul-Ehrlich-Str. 51-59
        63225  Langen Germany
        E-Mail
        PEI
        LinkedIn
        Annina Kurzay
        ESR 6, thor Straten's Lab, Center for Cancer Immunotherapy, Region Hovedstaden, University Hospital Herlev
        Herlev Ringvej 75
        2730 Herlev Denmark
        E-Mail
        CCIT
        LinkedIn
        Johanna Nimmerfroh
        ESR 7, Zippelius and Läubli's Lab, Cancer Immunology, Cancer Immunotherapy, Department of Biomedicine (DBM), Universität Basel
        Hebelstrasse 20
        4031 Basel Switzerland 
        E-Mail
        Department of Biomedicine
        LinkedIn
        Emanuele Carlini
        ESR 8, Kobold's Lab, Division of Clinical Pharmacology, Ludwig-Maximilians-Universität Munich
        Lindwurmstr. 2
        80337 Munich Germany
        E-Mail
        Division of Clinical Pharmacology
        LinkedIn
        Urheberschaft ungeklärt
        Dominic Schwarz
        ESR 9, Klein's Lab, Department Cancer Immunotherapy Discovery 3, Roche Pharma Research & Early Development, Roche Glycart AG, Roche Innovation Center Zurich
        Wagistrasse 10
        8952  Schlieren Switzerland
        Keine gültige E-Mail Adresse
        Roche
        LinkedIn
        Catarina Guerra
        ESR 10, Hawkin's Lab, InstilBio Inc
        48 Grafton Street
        Manchester M13 9XX UK
        Keine gültige E-Mail Adresse
        IntilBio
        LinkedIn
        Laura Marcos Kovandzic
        ESR 11, Zitvogel's Lab, UMR 1015 Immunologie des tumeurs immunothérapie contre le cancer Université Paris-Saclay
        114, rue Édouard-Vaillant
        94805 Villejuif-Cedex   Paris France
        E-Mail
        Université Paris-Saclay
        LinkedIn
        Adriano Carboniero
        ESR 12, Theurich's Lab, Gene Center Munich, Ludwig-Maximilians-Universität Munich
        Feodor-Lynen-Straße 25 and Department of Medicine III, LMU University Hospital
        81377 Munich Germany
        Gene Center
        LinkedIn
        Urheberschaft ungeklärt
        Valeria Durante
        ESR 13, Mittelstätt and Schallenberg's Group, R&D Reagents CAR technology research and translation, Team clinical T cell processing development Miltenyi Biotec B.V. & Co. KG
        Friedrich-Ebert-Straße 68
        51429 Bergisch Gladbach Germany
        E-Mail
        Miltenyi Biotec
        LinkedIn
        Thy Luu
        ESR 14, thor Straten's Lab, Center for Cancer Immunotherapy, Region Hovedstaden, University Hospital Herlev
        Herlev Ringvej 75
        2730 Herlev Denmark
        E-Mail
        CCIT
        LinkedIn
        Urheberschaft ungeklärt
        Imke Reith
        ESR 15, Lotem's Lab, Center for Melanoma and Cancer Immunotherapy Sharett Institute Hadassah Medical Organization, HMO
        POB12 000 Jerusalem Israel
        RFHMO
        LinkedIn
        • 12 beneficiaries
        • 5 associated partners
        • 12 academic partners
        • 4 industrial partners
        • 1 public authority
        • 7 countries


        Redakteurs Log-In
        Impressum | Datenschutz

        T-OP 

        • Conferences and workshops
          • Munich 2022
          • Manchester 2022
          • Copenhagen 2023
        • Network
        • Training and research
        • Call for position
        • Contact
        • Member Area